Scientific Advisory Board

---

• Professor, Harvard Medical School, Allergy and Immunology; 
• Director, Adverse Drug Reaction and Desensitization Program at Brigham and Women's Hospital

• Professor, Harvard Medical School; 
• Founder and Executive Director of the Pediatric MS Center of Excellence at Massachusetts General Hospital; 
• Senior scientist at the Ann Romney Neurologic Institute;
• Executive Director of the CLIMB Study, the largest ongoing study of MS patients in the US; 
• Chairperson, International Pediatric MS Study Group.

• Professor, University of Ottawa
• Executive Director, MS Research Unit at the Ottawa Hospital
• Lead Investigator, Canadian Bone Marrow Transplant Study in MS
• Director, Canadian Mesenchymal Stem Cell Transplantation in MS Study 
• Co-Director, International Mesenchymal Stem Cell Transplantation in MS Study Group. 
• Treasurer of the Americas Committee for Treatment and Research in MS (ACTRIMS).

• Assistant Professor, Department of Psychiatry, Division of Neuropsychiatry
• Chief Psychiatric Consultant, Multiple Sclerosis and Transverse Myelitis Clinics, Department of Neurology
• Attending Physician, HIV/AIDS Psychiatry Service,  Department of Psychiatry
• Johns Hopkins University School of Medicine

Emotionally intelligent, entrepreneurial Executive in the pharmaceutical and biotechnology industry with multiple drugs approved and approaching approval. These products are projected to be multi-billion dollar products and have created over $6 billion in market capitalization. Built and led successful teams in pharmaceutical research and development with over three decades of experience. Leadership positions include Executive position in business development for a top tier research medical school, decade long tenure as Executive Committee member of a publicly traded company, SVP of Global Research, and SVP of Quality. Directed internal and external international relationships. Therapeutic areas include Rare Diseases, Hemophilia, Pain, Oncology, Antivirals.